Bob Jacobus

Bob Jacobus serves as the CEO of OrthoTOM since May 2024, following a successful tenure as co-founder and CEO of AI Metrics from June 2019 to July 2023. Bob held the position of Managing Director at Brookline Investments between August 2015 and December 2018, focusing on venture capital investments and capital raising for technology companies in sectors such as FinTech, Biopharma, and Biotech. From December 2015 to September 2018, Bob was the CEO of Cahaba Pharmaceuticals, LLC and Saba Labs LLC, overseeing early-stage biotech companies. Bob also founded Premiere Transportes SA de CV, served as an Adjunct Professor of Finance at Birmingham-Southern College, and worked as a missionary from January 2009 to June 2010. Earlier career positions include investment banking roles at FTN Financial, Raymond James Financial, and Porter, White & Company. Bob holds a Bachelor of Engineering in Mechanical Engineering from the University of Colorado Boulder, an MBA from the University of Denver, and a Master’s Degree in Finance from The University of Alabama. Additional language training was completed at The Spanish Language Institute.